LSPN 19: AI ‘explosion’ and drug costs in Canada
17-10-2019
Novartis enters AI partnership with Oxford University
21-01-2019
Novartis
Novartis has teamed with Microsoft to launch a new artificial intelligence (AI) innovation lab, which it says has the potential to “transform” and “reimagine” medicine.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Novartis, Microsoft, AI, innovation, life science, human biology, medicine, pharmaceutical industry, oncology, patient costs, drug development
